Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A Report on the Safety of Acitretin Use in Renal Failure Patients on Hemodialysis

Shim PJ. et al, (2024), Clinical and Experimental Dermatology

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection.

Ahuja SK. et al, (2023), Nat Commun, 14

Research engagement by British early-career practitioners in nephrology: a multidisciplinary survey

Bottomley MJ. et al, (2022), BMJ Open, 12, e066212 - e066212

Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis

Tseng CI. et al, (2022), eJHaem

Reduced Pancreatic Cancer Survival During COVID-19 Pandemic

Brodey A. et al, (2022), Oncology Times, 44, 1,5 - 5

The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis

Madge O. et al, (2022), Journal of Clinical Medicine, 11, 2574 - 2574

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.

Brook MO. et al, (2022), BMJ Open, 12

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients

Bottomley MJ. et al, (2022)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients.

Bottomley MJ. et al, (2022), Front Immunol, 13

Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework.

Bottomley MJ. et al, (2022), Transpl Int, 35

DONOR CYTOMEGALOVIRUS SEROPOSITIVITY CLUSTERS WITH RISK FACTORS FOR DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTATION, BUT DOES NOT DIRECTLY CONTRIBUTE

Dumbill R. et al, (2021), TRANSPLANT INTERNATIONAL, 34, 189 - 189

OUTCOMES OF AKI IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19 INFECTION: A TRAINEE-LED, MULTICENTRE, INTERNATIONAL REGISTRY STUDY

Bottomley M. et al, (2021), TRANSPLANT INTERNATIONAL, 34, 396 - 396

Study Dataset for mHLA-DRd and Cancer Risk

Bottomley M. et al, (2021)

CD8+T CELL SENESCENCE IS A DISTINCT IMMUNOLOGICAL STATE THAT IDENTIFIES LONG-TERM RENAL TRANSPLANT RECIPIENTS AT INCREASED RISK OF FUTURE MALIGNANCY

Bottomley MJ. et al, (2020), TRANSPLANTATION, 104, S106 - S106

Predictive Factors for BKV Nephropathy in Renal Transplant Recipients with BK Viruria

Alshaer I. et al, (2019), AMERICAN JOURNAL OF TRANSPLANTATION, 19, 983 - 983

Differences in thrombotic and inflammatory markers comparing subjects with maturity onset diabetes of the young and type 2 diabetes

Bottomley MJ. et al, (2010), DIABETOLOGIA, 53, S116 - S116

Include forthcoming?